Bazaarvoice, Inc. to Present at the Credit Suisse Annual Technology, Media & Telecom Conference
Nov 29, 2016 21:05 pm UTC| Business
AUSTIN, Texas, Nov. 29, 2016 -- Bazaarvoice, Inc. (NASDAQ:BV), which is creating the world's smartest network of active shoppers, brands and retailers, today announced that Gene Austin, Chief Executive Officer, and Jim...
Nov 29, 2016 21:05 pm UTC| Business
SAN DIEGO, Nov. 29, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), announced today the closing of its underwritten public offering of 3,018,750 shares of its common stock, which includes 393,750 shares of common stock...
Ovid Therapeutics to Participate in Two Upcoming Investor Conferences
Nov 29, 2016 21:05 pm UTC| Business
NEW YORK, Nov. 29, 2016 -- Ovid Therapeutics, a privately-held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced its...
Galapagos increases share capital through warrant exercises
Nov 29, 2016 21:03 pm UTC| Business
Mechelen, Belgium, Nov. 29, 2016 -- Mechelen, Belgium; 29 November 2016 - Galapagos NV (Euronext NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 86,250 new...
Nov 29, 2016 21:02 pm UTC| Business
AUSTIN, Texas, Nov. 29, 2016 -- Superconductor Technologies Inc. (STI) (Nasdaq:SCON) has been selected as prime recipient of the $4.5 million program award provided by the U.S. Department of Energy’s (DOE) Office of...
MYR Group Inc. Announces Resignation of John P. Schauerman from Board of Directors
Nov 29, 2016 21:02 pm UTC| Business
ROLLING MEADOWS, Ill., Nov. 29, 2016 -- MYR Group Inc. (“MYR Group” or the “Company”) (NASDAQ:MYRG), a leading specialty contractor serving the electrical infrastructure market in the United States and Canada, announced...
Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals
Nov 29, 2016 21:01 pm UTC| Business
HAMPTON, N.J., Nov. 29, 2016 -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today it has completed its previously announced acquisition of Kolltan Pharmaceuticals, Inc., a privately held company focused on the...